各公司竞相争取进入公开市场的机会。 - Suppr

Suppr

超能文献

Companies jostle for access to public markets.

作者信息

Bouchie Aaron

出版信息

Nat Biotechnol. 2003 Dec;21(12):1413-4. doi: 10.1038/nbt1203-1413.

DOI:10.1038/nbt1203-1413

PMID:14647309

Abstract

摘要

相似文献

Companies jostle for access to public markets.

Nat Biotechnol. 2003 Dec;21(12):1413-4. doi: 10.1038/nbt1203-1413.

Evolving symbiosis--venture capital and biotechnology.

Nat Biotechnol. 2003 Sep;21(9):983-4. doi: 10.1038/nbt0903-983.

European markets target foreign biotechs.

Nat Biotechnol. 2003 Jul;21(7):719. doi: 10.1038/nbt0703-719.

Public markets show signs of life.

Nat Biotechnol. 2003 Aug;21(8):833-4. doi: 10.1038/nbt0803-833.

Hedge funds gain edge by doubling biotech investments.

Nat Biotechnol. 2006 Apr;24(4):373-4. doi: 10.1038/nbt0406-373.

The rise of European venture capital for biotechnology.

Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.

Korean biotechs seize opportunity to list on public markets.

Nat Biotechnol. 2005 Oct;23(10):1189-90. doi: 10.1038/nbt1005-1189.

Biotech holds steady in Q4.

Nat Biotechnol. 2004 Feb;22(2):135-6. doi: 10.1038/nbt0204-135.

IPOs: the narrow window closes?

Nat Biotechnol. 2004 Dec;22(12):1489. doi: 10.1038/nbt1204-1489.

Biotech IPOs--flop or pop?

Nat Biotechnol. 2004 Aug;22(8):949. doi: 10.1038/nbt0804-949.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Companies jostle for access to public markets.

Nat Biotechnol. 2003 Dec;21(12):1413-4. doi: 10.1038/nbt1203-1413.

Evolving symbiosis--venture capital and biotechnology.

Nat Biotechnol. 2003 Sep;21(9):983-4. doi: 10.1038/nbt0903-983.

European markets target foreign biotechs.

Nat Biotechnol. 2003 Jul;21(7):719. doi: 10.1038/nbt0703-719.

Public markets show signs of life.

Nat Biotechnol. 2003 Aug;21(8):833-4. doi: 10.1038/nbt0803-833.

Hedge funds gain edge by doubling biotech investments.

Nat Biotechnol. 2006 Apr;24(4):373-4. doi: 10.1038/nbt0406-373.

The rise of European venture capital for biotechnology.

Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.

Korean biotechs seize opportunity to list on public markets.

Nat Biotechnol. 2005 Oct;23(10):1189-90. doi: 10.1038/nbt1005-1189.

Biotech holds steady in Q4.

Nat Biotechnol. 2004 Feb;22(2):135-6. doi: 10.1038/nbt0204-135.

IPOs: the narrow window closes?

Nat Biotechnol. 2004 Dec;22(12):1489. doi: 10.1038/nbt1204-1489.

Biotech IPOs--flop or pop?

Nat Biotechnol. 2004 Aug;22(8):949. doi: 10.1038/nbt0804-949.